174 related articles for article (PubMed ID: 18514540)
21. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
[TBL] [Abstract][Full Text] [Related]
22. Variants of the ankyrin repeat domain 6 gene (ANKRD6) and muscle and physical activity phenotypes among European-derived American adults.
Van Deveire KN; Scranton SK; Kostek MA; Angelopoulos TJ; Clarkson PM; Gordon PM; Moyna NM; Visich PS; Zoeller RF; Thompson PD; Devaney JM; Gordish-Dressman H; Hoffman EP; Maresh CM; Pescatello LS
J Strength Cond Res; 2012 Jul; 26(7):1740-8. PubMed ID: 22580979
[TBL] [Abstract][Full Text] [Related]
23. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
[TBL] [Abstract][Full Text] [Related]
24. Schizophrenia Patient Shows a Rare Interleukin 15 Receptor alpha Variant Disrupting Signal Transduction.
Pan Y; Wang Z; Zhang G; Guo J; Zhu X; Zhou J; Zhang Z; Sun Z; Yang J; Kastin AJ; Pan W; Wu X; Zhang J; Wang X; Wang C; He Y
Curr Mol Med; 2019; 19(8):560-569. PubMed ID: 31244423
[TBL] [Abstract][Full Text] [Related]
25. Ancient Cytokine Interleukin 15-Like (IL-15L) Induces a Type 2 Immune Response.
Yamaguchi T; Chang CJ; Karger A; Keller M; Pfaff F; Wangkahart E; Wang T; Secombes CJ; Kimoto A; Furihata M; Hashimoto K; Fischer U; Dijkstra JM
Front Immunol; 2020; 11():549319. PubMed ID: 33193315
[TBL] [Abstract][Full Text] [Related]
26. The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells.
Sato N; Patel HJ; Waldmann TA; Tagaya Y
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):588-93. PubMed ID: 17202253
[TBL] [Abstract][Full Text] [Related]
27. Different NK cell developmental events require different levels of IL-15 trans-presentation.
Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
[TBL] [Abstract][Full Text] [Related]
28. The clinical significance and impact of interleukin 15 on keratinocyte cell growth and migration.
Jones AM; Griffiths JL; Sanders AJ; Owen S; Ruge F; Harding KG; Jiang WG
Int J Mol Med; 2016 Sep; 38(3):679-86. PubMed ID: 27460304
[TBL] [Abstract][Full Text] [Related]
29. The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation.
Wu Z; Xue HH; Bernard J; Zeng R; Issakov D; Bollenbacher-Reilley J; Belyakov IM; Oh S; Berzofsky JA; Leonard WJ
Blood; 2008 Dec; 112(12):4411-9. PubMed ID: 18796634
[TBL] [Abstract][Full Text] [Related]
30. Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population.
Carter KW; Hung J; Powell BL; Wiltshire S; Foo BT; Leow YC; McQuillan BM; Jennens M; McCaskie PA; Thompson PL; Beilby JP; Palmer LJ
Hum Genet; 2008 Oct; 124(3):199-206. PubMed ID: 18716798
[TBL] [Abstract][Full Text] [Related]
31. Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity.
Bergamaschi C; Rosati M; Jalah R; Valentin A; Kulkarni V; Alicea C; Zhang GM; Patel V; Felber BK; Pavlakis GN
J Biol Chem; 2008 Feb; 283(7):4189-99. PubMed ID: 18055460
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-15 in gene therapy of cancer.
Ochoa MC; Mazzolini G; Hervas-Stubbs S; de Sanmamed MF; Berraondo P; Melero I
Curr Gene Ther; 2013 Feb; 13(1):15-30. PubMed ID: 23157547
[TBL] [Abstract][Full Text] [Related]
33. The muscle strength and size response to upper arm, unilateral resistance training among adults who are overweight and obese.
Pescatello LS; Kelsey BK; Price TB; Seip RL; Angelopoulos TJ; Clarkson PM; Gordon PM; Moyna NM; Visich PS; Zoeller RF; Gordish-Dressman HA; Bilbie SM; Thompson PD; Hoffman EP
J Strength Cond Res; 2007 May; 21(2):307-13. PubMed ID: 17530988
[TBL] [Abstract][Full Text] [Related]
34. Cell-specific interleukin-15 and interleukin-15 receptor subunit expression and regulation in pneumococcal pneumonia--comparison to chlamydial lung infection.
Hocke AC; Lampe MP; Witzenrath M; Mollenkopf H; Zerrahn J; Schmeck B; Kessler U; Krüll M; Hammerschmidt S; Hippenstiel S; Schütte H; Suttorp N; Rosseau S
Cytokine; 2007 May; 38(2):61-73. PubMed ID: 17611121
[TBL] [Abstract][Full Text] [Related]
35. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
36. Association of the IL-15 and IL-15Rα genes with celiac disease.
Escudero-Hernández C; Plaza-Izurieta L; Garrote JA; Bilbao JR; ; Arranz E
Cytokine; 2017 Nov; 99():73-79. PubMed ID: 28738233
[TBL] [Abstract][Full Text] [Related]
37. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice.
Koka R; Burkett PR; Chien M; Chai S; Chan F; Lodolce JP; Boone DL; Ma A
J Exp Med; 2003 Apr; 197(8):977-84. PubMed ID: 12695489
[TBL] [Abstract][Full Text] [Related]
38. Frequencies of IL-15Rα+ cells in patients with Behçet's disease and the effects of overexpressing IL-15Rα+ on disease symptoms in mice.
Islam SMS; Choi B; Choi J; Lee ES; Sohn S
Cytokine; 2018 Oct; 110():257-266. PubMed ID: 29396044
[TBL] [Abstract][Full Text] [Related]
39. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models.
Guo S; Smeltz RB; Nanajian A; Heller R
Front Immunol; 2020; 11():614667. PubMed ID: 33628206
[TBL] [Abstract][Full Text] [Related]
40. Adipocytes: A Novel Target for IL-15/IL-15Rα Cancer Gene Therapy.
Xiao R; Mansour AG; Huang W; Chrislip LA; Wilkins RK; Queen NJ; Youssef Y; Mao HC; Caligiuri MA; Cao L
Mol Ther; 2019 May; 27(5):922-932. PubMed ID: 30833178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
